Aries Wealth Management Invitae Corp Transaction History

Aries Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	SELL	$1.71 - $3.61 $3,420 - $7,220	-2,000 Reduced 16.67%	10,000 $0
Q3 2022 Nov 02, 2022	BUY	$1.9 - $8.63 $22,800 - $103,560	12,000 New	12,000 $31,000
Q4 2021 Jan 18, 2022	BUY	$14.7 - $28.67 $411,600 - $802,760	28,000 New	28,000 $428,000
Q1 2021 Apr 20, 2021	SELL	$33.06 - $56.93 $132,240 - $227,720	-4,000 Closed	0 $0
Q4 2020 Jan 22, 2021	BUY	$39.09 - $57.4 $156,360 - $229,600	4,000 New	4,000 $205,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Aries Wealth Management with notifications on news.